Scientists from A*STAR Infectious Diseases Labs (A*STAR IDL), Nanyang Technological University, Singapore's Lee Kong Chian ...

Mycobacterium abscessus is a non-tuberculous mycobacterium (NTM) that causes lung infections and is growing increasingly resistant to clarithromycin, a crucial antibiotic used to treat NTM infections ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Epetraborole’s potent activity against M. abscessus supports further investigation as a potential therapy for disease with an estimated all-cause mortality of 45% About AN2 Therapeutics, Inc. AN2 ...

Scientists at St. Jude Children's Research Hospital have found a way to use a bacterium's own drug resistance mechanisms against itself, presenting a potentially safer and more effective way to treat ...

Mycobacterium abscessus can cause dangerous lung infections. Treatment usually requires a combination of antibiotics for more than a year. Researchers in China report that curcumin, found in turmeric, ...

Researchers Véronique Dartois, Ph.D., and Thomas Dick, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation in Nutley, N.J. The pair work with laboratory samples in developing their ...

At the center of this resistance is the WhiB7 “resistome,” a set of antibiotic-limiting genes in M. abscessus. “WhiB7 is a master regulator of ribosomal stress, and many antibiotics used to treat ...

Smoking can really clog up the lungs, even for people who’ve never been near a cigarette. Turns out that smoking habits from the early 1900s are still inflicting damage—not on tobacco users or their ...

MENLO PARK, Calif.--(BUSINESS WIRE)-- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today ...